Ganoderma lucidum (Curt.: Fr.) Karst. - health-promoting properties. A review

• Autorzy: Siwulski M. , Sobieralski K. , Golak-Siwulska I. , Sokol S. , Sekara A.

Warianty tytułu

PL

Lakownica lśniąca Ganoderma lucidum (Curt.: Fr.) Karst. - właściwości prozdrowotne. Przegląd

• Języki publikacji: EN

Abstrakty

EN

This paper presents the characteristics of the species Ganoderma lucidum in terms of health-promoting properties. This species is rare in Poland, and is subject to strict protection. Reishi is classified as a medicinal mushroom which fruiting bodies are characterized by a content of active substances with diverse positive effects on human health. G. lucidum is particularly rich source of bioactive compounds, which are obtained from fruiting bodies, mycelium and spores of this species. The therapeutic effect of G. lucidum extracts has been demonstrated in many scientific studies. The most important pharmacological and physiological effects include: immunomodulatory, anti-cancer, anti-inflammatory, antiviral, anti-atherosclerosis, antidiabetic and antiaging. Reishi has also a beneficial effect on liver cells and the cardiovascular system and protects in case of stomach ulcers. Due to its properties G. lucidum can be used in the prevention and treatment of life-threatening diseases, such as cancer, stroke and heart diseases.

PL

Opracowanie przedstawia charakterystykę lakownicy lśniącej (Ganoderma lucidum) pod względem właściwości prozdrowotnych. Gatunek ten w Polsce występuje rzadko i jest objęty całkowitą ochroną. Lakownica lśniąca zaliczana jest do grzybów leczniczych, których owocniki charakteryzują się zawartością substancji aktywnych o wielokierunkowym pozytywnym wpływie na zdrowie człowieka. G. lucidum jest wyjątkowo bogatym źródłem związków bioaktywnych, które pozyskuje się z owocników, grzybni oraz zarodników tego gatunku. W wielu badaniach naukowych wykazano efekt leczniczy ekstraktów z lakownicy lśniącej. Do najważniejszych farmakologicznych i fizjologicznych oddziaływań należy zaliczyć: immunomodulujące, antynowotworowe, przeciwzapalne, przeciwbakteryjne, przeciwwirusowe, antymiażdżycowe, przeciwcukrzycowe oraz przeciwstarzeniowe. Lakownica lśniąca wywiera również korzystny wpływ na komórki wątroby oraz układ krążenia, a także działa ochronnie w przypadku wrzodów żołądka. Ze względu na wymienione właściwości, G. lucidum może być wykorzystana w profilaktyce i leczeniu zagrażających życiu chorób, takich jak nowotwory, udar mózgu oraz choroby serca.

• Wydawca: -
• Czasopismo: Herba Polonica
• Rocznik: 2015
• Tom: 61
• Numer: 3
• Opis fizyczny: p.105-118,ref.

Twórcy

autor

Siwulski M.

• Department of Vegetable Crops, Poznan University of Life Sciences, Dabrowskiego 159, 60-594 Poznan, Poland

autor

Sobieralski K.

• Department of Vegetable Crops, Poznan University of Life Sciences, Dabrowskiego 159, 60-594 Poznan, Poland

autor

Golak-Siwulska I.

• Department of Vegetable Crops, Poznan University of Life Sciences, Dabrowskiego 159, 60-594 Poznan, Poland

autor

Sokol S.

• Department of Biosystematics, Opole University, Oleska 22, 45-052 Opole, Poland

autor

Sekara A.

• Department of Vegetable and Medicinal Plants, University of Agriculture in Krakow, 29 Listopada 54, 31-425 Krakow, Poland

Bibliografia

• 1. Wasser SP. Medicinal mushroom science, history, current status, future trends, and unsolved problems. Int J Med Mush 2010; 12(1):1-16.
• 2. Wasser SP. Current finding, future trends, and unsolved problems in studies of medicinal mushrooms. Appl Microbiol Biotechnol 2011; 89:1323-1332.
• 3. Rathee S, Rathee D, Rathee D, Kumar V, Rathee P. Mushrooms as therapeutic agents. Braz J Pharmacognosy 2012; 22(2):459-474.
• 4. Wasser SP, Akavia E. Regulatory issues of mushrooms as functional foods and dietary supplements, safety and efficacy. In.: Cheung PCK. (ed.). Mushrooms as functional foods. New York. Wiley, 2008:199-221.
• 5. De Silva DD, Rapior S, Fons F, Bahkali AH, Hyde KD. Medicinal mushrooms in supportive cancer therapies, an approach to anti-cancer effects and putative mechanisms of action. Fungal Diversity 2012, 55:1-35.
• 6. Index Fungorum http://www.indexfungorum.org/ dostęp 4.05.2015.
• 7. Chang ST, Buswell JA. Medicinal Mushrooms: a prominent source of nutriceuticals for the 21st century. Curr Topics Nutraceut Res 2003; 1(3):257-280.
• 8. Stamets P. Growing gourmet and medicinal mushrooms. 3rd ed. Berkeley, CA. Ten Speed Press 2000:355-369.
• 9. Sokół S. O współczesnej systematyce europejskich gatunków rodzaju Ganoderma. Prace Nauk Uniw Śląskiego, Acta Biol Silesiana, Katowice 2000; 35(52):200-207.
• 10. Hagara L, Antonin V, Baier J. Houby, Aventinum, Praha 1999; 416 pp.
• 11. Grys A, Hołderna-Kędzia E, Łowicki Z. Ganoderma lucidum – grzyb o cennych właściwościach farmakologicznych. Postępy Fitoterapii 2011; 1:28-33.
• 12. Grienke U, Kaserer T, Pfluger F, Mair CE, Langer T, Schuster D et al. Accessing biological actions of Ganoderma secondary metabolites by in silico profiling. Phytochemistry 2014; doi:10.1016/j.phytochem.2014.10.010.
• 13. Skalicka-Woźniak K, Szypowski J, Łoś R, Siwulski M, Sobieralski K, Głowniak K et al. Evaluation of polysaccharides content in fruit bodies and their antimicrobial activity of four Ganoderma lucidum (Fr.) Karst. strains cultivated on different wood type substrates. Acta Soc Bot Pol 2012; 81(1):17-21.
• 14. Xu Z, Chen X, Zhong Z, Chen L, Wang Y. Ganoderma lucidum polysaccharides: immunomodulation and potential anti-tumor activities. Am J Chinese Med 2011; 39(1):15-27.
• 15. Kao CHJ, Jesuthasan AC, Bishop KS, Glucina MP, Ferguson LR. Anti-cancer activities of Ganoderma lucidum: active ingredients and pathways. Function Foods Health Dis 2013; 3(2):48-65.
• 16. Wiater A, Paduch R, Choma A, Pleszczyńska M, Siwulski M, Dominik J et al. Biological study on carboxymethylated (1→3)-α-D-glucans from fruiting bodies of Ganoderma lucidum. Int J Biol Macromolecules 2012; 51(5):1014-1023.
• 17. Zhu L, Luo X, Tang Q, Liu Y, Zhou S, Yang Y et al. Isolation, purification, and immunological activities of a low-molecular-weight polysaccharide from the Lingzhi or Reishi medicinal mushroom Ganoderma lucidum (Higher Basidiomycetes). Int J Med Mush 2013; 15 (4):407-414.
• 18. Chen XP, Chen Y, Li SB, Chen YG, Lan JY, Liu LP. Free radical scavenging of Ganoderma lucidum polysaccharides and its effect on antioxidant enzymes and immunity activities in cervical carcinoma rats. Carbohyd Polym 2009; 77:389–393.
• 19. Liu W, Xu J, Jing P, Yao W, Gao X, Yu L. Preparation of a hydroxypropyl Ganoderma lucidum polysaccharide and its physicochemical properties. Food Chem 2010; 122(4):965-971.
• 20. Meng G, Zhua H, Yangb S, Wua F, Zhengc H, Chenc E et al. Attenuating effects of Ganoderma lucidum polysaccharides on myocardialcollagen cross-linking relates to advanced glycation end product and antioxidantenzymes in high-fat-diet and streptozotocin-induced diabetic rats. Carbohyd Polym 2011; 84:180-185.
• 21. Pillai TG, Nair CK, Janardhanan KK. Polysaccharides isolated from Ganoderma lucidum occurring in Southernparts of India, protects radiation induced damages both in vitro and in vivo. Environment Toxicol Pharmacol 2008; 26:80-85.
• 22. Kozarski M, Klaus A, Nikisic M, Jakovljevic D, Helsper JPFG, Van Griensven LJLD. Antioxidative and immunomodulating activities of polysaccharide extracts of the medicinal mushrooms Agaricus bisporus, Agaricus brasiliensis, Ganoderma lucidum and Phellinus linteus. Food Chem 2011; 129:1667-1675.
• 23. Yamin S, Shuhaimi M, Arbakariya A, Fatimah AB, Khalilah AK, Anas O et al. Effect of Ganoderma lucidum polysaccharides on the growth of Bifidobacterium spp. as assessed using real-time PCR. Int Food Res J 2012; 19(3):1199-1205.
• 24. Huie CW, Di X. Chromatographic and electrophoretic methods for Lingzhi pharmacologically active components. J Chromatogr B 2004; 812:214-257.
• 25. Ma L, Wu F, Chen RY. Analysis of triterpene constituents from Ganoderma lucidum. Acta Pharm Sin 2003; 38:50-52.
• 26. Russel R, Paterson M. Ganoderma - A therapeutic fungal biofactory. Phytochem 2006; 67:1985-2001.
• 27. Liu J, Shimizu K, Tanaka A, Shinobu W, Ohnuki K, Nakamura T et al.Target proteins of ganoderic acid DM provides clues to various pharmacological mechanisms. Sci Rep 2012; 2:905, doi 10.1038/srep00905.
• 28. Leskosek-Cukalovic I, Despotovic S, Lakic N, Niksic M, Nedovic V, Tesovic V. Ganoderma lucidum – medicinal mushroom as a raw material for beer with enhanced functional properties. Food Res Int 2010; 43:2262-2269.
• 29. Sliva D. Ganoderma lucidum (Reishi) in cancer treatment. Integr Cancer Ther 2003; 2:358-364.
• 30. Liu J, Shimizu K, Konishi F, Noda K, Kumamoto S, Kurashiki K et al. Anti-androgenic activities of the triterpenoids fraction of Ganoderma lucidum. Food Chem 2007; 100:1691-1696.
• 31. Nahata A. Ganoderma lucidum: A potent medicinal mushroom with numerous health benefits. Pharmaceut Anal Acta 2013; 4(10):1-4.
• 32. Liu J, Shiono J, Shimizu K, Kukita A, Kukita T, Kondo R. Ganoderic acid DM: anti-androgenic osteoclastogenesis inhibitor. Bioorg Med Chem Lett 2009; 19:2154-2157.
• 33. Zhang Y, Huang N, Zhang X, Luo J. Effect of Ganoderma lucidum triterpenoids on the learning and memory ability and brain glutamate levels in mice aging model. J Neurol Neurorehabil 2011; 8(1):31-34.
• 34. Lin C-N, Fann Y-F, Cheung M-I. Steroids of formosan Ganoderma tsugae. Phytochem 1997; 46:1143-1146.
• 35. Wang H, Ng TB. Ganodermin, an antifungal protein from fruiting bodies of the medicinal mushroom Ganoderma lucidum and its effect on hepatic damage caused by benzo(a)pyrene. J Ethnopharmacol 2006; 107:297-303.
• 36. Ooi VEC, Liu F. Immunomodulation and anti-cancer activity of polysaccharide-protein complexes. Curr Med Chem 2000; 7(7):715-729.
• 37. Zhou X, Lin J, Yin Y, Zhao J, Sun X, Tang K. Ganodermataceae: natural products and their related pharmacological functions. Am J Chinese Med 2007; 35(4):559-574.
• 38. Gao JL, Leung KS, Wang YT, Lai CM, Li SP, Hu LF et al. Qualitative and quantitative analyses of nucleosides and nucleobases in Ganoderma spp. by HPLC-DAD-MS. J Pharm Biomed Anal 2007; 44 (3):801-811.
• 39. Kawagishi H, Fukuhara F, Sazuka M, Kawashima A, Mitsubori T, Tomita T. 5’-Deoxy-5’-methylsulphinyladenosine, a platelet aggregation inhibitor from Ganoderma lucidum. Phytochem 1993; 32:239-241.
• 40. Zheng L, Si J, Wong Y-S. Ergosterol peroxide and 9,11-dehydroergosterol peroxide from Ling Zhi or Reishi medicinal mushroom, Ganoderma lucidum (W. Curt.: Fr.) P. Karst. (Aphyllophoromycetideae) mycelia inhibit the growth of human breast adenocarcinoma MCF-7 cells. Int J Med Mushrooms 2009; 11(3):249-257.
• 41. Liu JJ, Huang WH, Lv ML, Si JP, Guo BL, Li SJ. Determination of ergosterol in Ganoderma lucidum from different varieties and cultured tree species by HPLC. Zhong Yao Cai 2011; 34 (2):187-190.
• 42. Pharmacopoeia of The People’s Republic of China. Chemical Industry Press, Michigan University, USA, 2000, T1: pp.1331.
• 43. Reishi Mushroom Ganoderma lucidum. Standards of analysis, quality control, and therapeutics. In: American Herbal Pharmacopoeia and Therapeutic Compendium, Roy Upton Herbalist (ed.), Scotts Valley, USA 2006.
• 44. Boh B, Berovic M, Zhang J, Zhi-Bin L. Ganoderma lucidum and its pharmaceutically active compounds. Biotechnol Ann Rev 2007; 13:265-301.
• 45. Wasser SP. Reishi or Ling Zhi (Ganoderma lucidum). In: Coates PM, Blackman MR, Cragg GM, Levine M, Moss J, White JD. (eds.) Encyclopedia of Dietary Supplements. New York. Marcel Dekker 2005:603-622.
• 46. Sanodiya BS, Thakur GS, Baghel RK, Prasad GBKS, Bisen PS. Ganoderma lucidum: a potent pharmacological macrofungus. Curr Pharm Biotechnol 2009; 10(8):717-742.
• 47. Song B-J, Zhu X-J, Wei L-N. Effect of Ganoderma lucidum spores on immune modulation and inhibiting tumor in mice. J Harbin Med Univ 2010; 44(5):464-466.
• 48. Calder PC. Immunonutrition. Br Med J 2003; 327:117.
• 49. Zhong L, Jiang DZ, Wang QR. Effects of Ganoderma lucidum (Leyss ex Fr) Karst compound on the proliferation and differentiation of K562 leukemic cells. J Hunan Med Univ 1999; 24:521-524.
• 50. Qu H-G, Gao L, He D, Liu C, Yan W, Gao S et al. Effect of reversion of Ganoderma lucidum polysaccharides on cisplatin resistant in ovarian cancer cells and its mechanism. J Jilin Univ (Med Edition) 2011; 37(2):250-254.
• 51. Nie Y, Zhao S, Zhao G, Hou Y. Ganoderma lucidum spores oil-induced anti-tumor effect and immunological function change in tumorbearing mice. Immunol J 2010; 26(12):1052-1055.
• 52. Guo Q, Sun H, Liang C, Zhang S, Liu Z, Sun F. Inhibiting and apoptosis-inducing effects of recombinant Ganoderma lucidum immunoregulatory protein on HL60 cells. Chin J Immunol 2010; 26:520-522.
• 53. Gao Y, Zhou SH, Huang M, Xu A. Antibacterial and antiviral value of the genus Ganoderma P. Karst. species (Aphyllophoromycetideae): a review. Int J Med Mushrooms 2003; 5 (3):235-246.
• 54. Suay I, Arenal F, Asensio FJ, Basilio A, Cabello MA, Diez MT et al. Screening of Basidiomycetes for antimicrobial activities. An Van Leeuw J Microb 2000; 78:129-139.
• 55. Heleno SA, Ferreira ICFR, Esteves AP, Ciric A, Glamoclija J, Martins A et al. Antimicrobial and demelanizing activity of Ganoderma lucidum extract, p-hydroxybenzoic and cinnamic acids and their synthetic acetylated glucuronide methyl esters. Food Chem Toxicol 2013; 58: 95-100.
• 56. Shah P, Modi HA, Shukla MD, Lahiri SK. Preliminary phytochemical analysis and antibacterial activity of Ganoderma lucidum collected from Dang District of Gujarat, India. Int Curr Microbiol Appl Sci 2014; 3(3):246-255.
• 57. Eo SK, Kim YS, Lee CK, Han SS. Possible mode of antiviral activity of acidic protein bound polysaccharide isolated from Ganoderma lucidum on herpes simplex viruses. J Ethnopharmacol 2000; 72:475-481.
• 58. Babitskaya VG, Bisko NA, Scherba VV, Mitropolskaya NY. Some biologically active substances from medicinal mushroom Ganoderma lucidum. Int J Med Mushrooms 2003; 5:301.
• 59. Hernandez-Marquez E, Lagunas-Martinez A, Bermudez-Morales VH, Burgete-Garcfa AI, Leon-Rivera I, Montiel-Arcos E et al. Inhibitory activity of Lingzhi or Reishi medicinal mushroom, Ganoderma lucidum (Higher Basidiomycetes) on transformed cells by Human Papillomavirus. Int J Med. Mushrooms 2014; 16 (2):179-187.
• 60. Gao Y, Lan J, Dai X, Ye J, Zhou S. A phase I/II study of ling zhi mushroom Ganoderma lucidum (W.Curt.,Fr.) Lloyd (Aphyllophoromycetidae) extract in patients with type II diabetes mellitus. Int J Med Mushrooms 2004; 6: 33-39.
• 61. Mao C, Li X, Zhang H, Lin G, Li W. Effect of Ganoderma lucidum on the oxidative stress in the kidney in diabetic rat kidney. J Sichuan Tradition Chin Med 2009; 27(7):27-29.
• 62. Wang MY, Liu Q, Che QM, Lin ZB. Effects of total triterpenoids extract from Ganoderma lucidum (Curt.: Fr.) P. Karst. (Reishi mushroom) on experimental liver injury models induced by carbon tetrachloride or d-galactosamine in mice. Int J Med Mushrooms 2002; 4:337-342.
• 63. Zhou S, Gao Y, Chen G, Dai X, Ye J, Gao H. A phase I/II study of a Ganoderma lucidum (Curt.,Fr.) P. Karst. (Ling Zhi, Reishi mushroom) extract in patients with chronic hepatitis B. Int J Med Mushrooms 2002; 4 (4):321-328.
• 64. Jin H, Zhang G, Cao X, Zhang M, Long J, Luo B et al. Treatment of hypertension by Linzhi combined with hypotensor and its effects on arterial, arteriolar and capillary pressure microcirculation. In: Microcirculatory Approach to Asian Traditional Medicine: Strategy for the Scientific Evaluation. Excerpta Medica, International Congress Series Elsevier, Amsterdam, NY, 1996:131-138.
• 65. Wang Z, Gu H, Yi S. Molecular mechanisms of Taishan Ganoderma lucidum amylose in prevention of rat atherosclerosis. Chin J Pathophysiol 2009; 25(12):2310-2313.
• 66. Yang L-J, You Y-H, Lin Z-B, Lin Y-F. Protective effects of Ganoderma lucidum polysaccharides peptide on human umbilical vein endothelial cells injury by reactive oxygen species. Chin Pharmacol Bull 2010; 26(5):657-660.
• 67. Hasnat MA, Pervin M, Cha KM, Kim SK, Lim BO. Anti-inflammatory activity on mice of extract of Ganoderma lucidum grown on rice via modulation of MAPK and NF-κB pathways. Phytochem 2014; DOI:10.1016/j.phytochem.2014.10.019.
• 68. Gupta A, Kirar V, Keshri GK, Gola S, Yadav A, Negi PS et al. Wound healing activity of an aqueous extract of the Lingzhi or Reishi medicinal mushroom Ganoderma lucidum (Higher Basidiomycetes). Int J Med Mushrooms 2014; 16 (4):345-354.